Lanean...
Crystal structure of the thalidomide analog (3aR*,7aS*)-2-(2,6-dioxopiperidin-3-yl)hexahydro-1H-isoindole-1,3(2H)-dione
The title compound, C(13)H(16)N(2)O(4), crystallizes in the monoclinic centrosymmetric space group, P2(1)/c, with four molecules in the asymmetric unit, thus there is no crystallographically imposed symmetry and it is a racemic mixture. The structure consists of a six-membered unsaturated ring boun...
Gorde:
| Argitaratua izan da: | Acta Crystallogr E Crystallogr Commun |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
International Union of Crystallography
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6218906/ https://ncbi.nlm.nih.gov/pubmed/30443388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1107/S2056989018014317 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|